• First patient dosed for Phase I/II trial of avapritinib in advanced GIST biospectrumasia
    August 26, 2019
    CStone announces on a registrational bridging study in China which includes a Phase I dose-escalation study and Phase II dose-expansion study to evaluate safety, pharmacokinetics and efficacy of avapritinib in patients with metastatic gastrointestinal str
PharmaSources Customer Service